Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Famous Versatile Brands: Your Decision - 2Regeneron's experimental therapy combo effective in untreated cancer patients
- 3Human evolution’s biggest mystery has started to unravel. How 2025 tipped the scales
- 410 Energizing Vocations in the Innovation Business
- 5Red Sea arena: Yemen’s Houthis open fourth front in Iran war, with global implications
- Bondi Beach survivor criticizes police for inaction during terror attack
- If evolution is real, then why isn’t it happening now? An anthropologist explains that humans actually are still evolving
- Reporter's Notebook: The Post embeds with foreign armies visiting the IDF
- 5 Movies That Leaving an Imprint with Inventive Innovation
- Recalled "super greens" supplement linked to dozens of salmonella cases, CDC says
- Astronauts beam home Christmas wishes from International Space Station: 'I think we may be orbiting a little higher than Santa' (video)
- Why home maintenance deserves a spot in the annual health and budget plans
- Opening Innovativeness: Moving Thoughts and Tasks
- German hauliers warn soaring energy prices may soon impact consumers
